Newsletter Signup | Join Community
Stivarga precision cancer medicine helps prolong survival in individuals with advanced colo-rectal cancer.
Genomic testing dictates how precision cancer medicines, chemotherapy & surgery are used to treat advanced colon cancer
Surgery, chemotherapy, biomarker testing and precision cancer medicines all part of stage III colon cancer treatment.
Tumor Mutational Burden Appears-A Useful Adjunct to MSI in Determining Optimal Colon Cancer Treatment?
The BEACON clinical trial defines new treatment for BRAF V600E - mutant advanced colorectal cancer
Genomic testing identifies genetic targets that can be treated with precision cancer medicines avoiding chemotherapy
TAPUR study identifies BRAF V600 as target in colorectal cancer, additional study enrollment ongoing
Updates on screening, treatment advances and prevention of Colon and Rectal Cancer.
Avastin® treatment significantly improves survival advanced colon cancer - understand side effects how its best used.
Oncotype DX identifies colon cancers with high risk of recurrence and helps determine necessity of adjuvant chemotherapy
Did your doctor do an OncotypeDX colon cancer test? Curious how many people with stage II or III…
What have you found that helps with neuropathy?…
Has anyone's oncologist recommended "shorter duration" chemotherapy for stage 2 or 3 colon cancer to…
How many people take an Aspirin a day?
Duke study suggest same bacteria that cause gastric cancer may be associated with colon cancer:…
Bisphosphonates May Reduce Risk of Colorectal Cancer